Table II.
Term | Count | P-value | FDR | Genes |
---|---|---|---|---|
hsa04110: Cell cycle | 6 | 1.55×10−6 | 1.01×10−4 | PLK1, CCNB2, BUB1, CCNA2, CHEK1, E2F1 |
hsa04914: Progesterone-mediated oocyte maturation | 5 | 9.06×10−6 | 2.94×10−4 | CCNB2, BUB1, PLK1, PGR, CCNA2 |
hsa04114: Oocyte meiosis | 5 | 2.43×10−5 | 5.26×10−4 | CCNB2, BUB1, PLK1, AURKA, PGR |
hsa05206: MicroRNAs in cancer | 5 | 1.00×10−3 | 1.33×10−2 | STMN1, TP63, EZH2, E2F1, KIF23 |
hsa04115: P53 signaling pathway | 3 | 1.03×10−3 | 1.33×10−2 | CCNB2, RRM2, CHEK1 |
hsa05222: Small cell lung cancer | 3 | 2.02×10−3 | 2.18×10−2 | FN1, E2F1, CKS2 |
hsa05161: Hepatitis B | 3 | 8.31×10−3 | 7.71×10−2 | E2F1, BIRC5, CCNA2 |
Term, enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway; count, the number of differentially expressed genes of each term; P-value, P-value of enrichment analysis; FDR, false discovery rate.